Tesla
TSLA
Apple
AAPL
Meta Platforms
META
4
Microsoft
MSFT
5
Netflix
NFLX
US Stock MarketDetailed Quotes
TGTX TG Therapeutics
- 42.990
- +1.100+2.63%
Close Mar 21 16:00 ET
- 42.990
- 0.0000.00%
Post 19:56 ET
6.75BMarket Cap286.60P/E (TTM)
43.150High41.190Low4.65MVolume41.620Open41.890Pre Close198.72MTurnover3.18%Turnover Ratio286.60P/E (Static)157.07MShares43.15052wk High30.36P/B6.29BFloat Cap12.93052wk Low--Dividend TTM146.38MShs Float149414.006Historical High--Div YieldTTM4.68%Amplitude0.956Historical Low42.723Avg Price1Lot Size
TG Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -28.98%-40.52M | -94.10%-25.64M | -114.58%-12.21M | 113.18%5.54M | 86.30%-8.21M | 82.17%-31.41M | 44.66%-13.21M | 342.66%83.7M | 14.48%-42.01M | 12.79%-59.9M |
| Net income from continuing operations | 84.52%23.38M | 261.84%23.33M | -96.59%3.88M | 114.45%6.88M | 72.71%-10.71M | 105.66%12.67M | 81.63%-14.42M | 418.08%113.93M | -17.52%-47.61M | 43.15%-39.23M |
| Operating gains losses | --4.61M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -33.81%280K | -31.87%62K | -49.21%64K | -15.29%72K | -32.23%82K | -17.86%423K | -27.78%91K | -2.33%126K | -35.11%85K | -6.20%121K |
| Other non cash items | -5.73%4.2M | -27.34%954K | 31.39%1.04M | -10.75%1.2M | 0.00%1.01M | 0.25%4.45M | 19.80%1.31M | -53.17%790K | 93.08%1.34M | 4.66%1.01M |
| Change In working capital | -29.10%-109.3M | -654.44%-60.74M | 20.65%-31.83M | -30.44%-10.67M | 78.58%-6.07M | -5,040.19%-84.66M | -147.33%-8.05M | -447.47%-40.11M | 2.85%-8.18M | -871.66%-28.32M |
| -Change in receivables | -52.84%-78.09M | -14.31%-13.46M | -47.09%-32.12M | -110.20%-18.63M | -61.07%-13.89M | -3,778.40%-51.09M | ---11.77M | -24,913.64%-21.84M | -1,188.57%-8.86M | -1,870.64%-8.62M |
| -Change in inventory | -80.98%-66.85M | -350.78%-24.82M | -0.16%-2.54M | -29.82%-2.56M | -37.17%-36.93M | ---36.94M | ---5.51M | ---2.54M | ---1.97M | ---26.92M |
| -Change in payables and accrued expense | 11,794.79%22.84M | -1,582.53%-38.01M | 154.25%11.67M | -3.44%8.96M | 308.01%40.22M | 101.74%192K | -84.39%2.56M | -253.69%-21.51M | 182.95%9.28M | 196.93%9.86M |
| -Change in other current assets | -123.10%-6.32M | 122.07%16.73M | -2,339.18%-25.59M | 115.69%1.05M | 156.81%1.49M | -134.60%-2.83M | 2,122.42%7.53M | -394.81%-1.05M | -616.83%-6.69M | -138.81%-2.62M |
| -Change in other current liabilities | 447.00%1.64M | 935.71%580K | -1,388.89%-1.39M | -87.27%14K | 9,280.77%2.44M | 645.45%300K | -80.21%56K | 109.97%108K | -84.24%110K | -44.68%26K |
| -Change in other working capital | 206.13%17.48M | -90.17%-1.76M | 170.28%18.14M | 1,410.53%498K | 1,684.21%602K | 3,857.24%5.71M | -2,336.84%-926K | 17,765.79%6.71M | 0.00%-38K | 0.00%-38K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -28.98%-40.52M | -94.10%-25.64M | -114.58%-12.21M | 113.18%5.54M | 86.30%-8.21M | 82.17%-31.41M | 44.66%-13.21M | 342.66%83.7M | 14.48%-42.01M | 12.79%-59.9M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 97.95%-1.04M | 135.28%15.79M | 69.12%-9.33M | -94.21%1.77M | -50.05%-9.26M | -153.09%-50.65M | -375.09%-44.76M | -911.00%-30.23M | 193.87%30.5M | 85.88%-6.17M |
| Net PPE purchase and sale | ---45K | ---21K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net investment purchase and sale | 98.04%-991K | 135.32%15.81M | 69.20%-9.31M | -94.21%1.77M | -50.05%-9.26M | -153.27%-50.65M | -375.04%-44.76M | -912.36%-30.23M | 193.87%30.5M | 85.87%-6.17M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 97.95%-1.04M | 135.28%15.79M | 69.12%-9.33M | -94.21%1.77M | -50.05%-9.26M | -153.09%-50.65M | -375.09%-44.76M | -911.00%-30.23M | 193.87%30.5M | 85.88%-6.17M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 76.78%128.53M | -607,100.00%-6.07M | 31,836.82%134.45M | -99.71%135K | -99.96%10K | 18,694.63%72.71M | -102.04%-1K | 53.09%421K | 34,749.63%47.05M | 3,069.18%25.24M |
| Net issuance payments of debt | 449.05%137.26M | --0 | --137.26M | ---- | ---- | 2,664.10%25M | --0 | --0 | --0 | 2,664.10%25M |
| Net common stock issuance | -118.92%-8.76M | -661,000.00%-6.61M | -215,000.00%-2.15M | ---- | ---- | --46.3M | ---1K | --1K | ---- | ---- |
| Proceeds from stock option exercised by employees | -40.42%914K | --570K | -52.62%199K | -82.02%135K | -97.25%10K | 162.67%1.53M | --0 | 52.73%420K | 456.30%751K | 190.40%363K |
| Net other financing activities | -611.20%-889K | ---31K | ---- | ---- | ---- | ---125K | --0 | ---- | ---- | ---125K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 76.78%128.53M | -607,100.00%-6.07M | 31,836.82%134.45M | -99.71%135K | -99.96%10K | 18,694.63%72.71M | -102.04%-1K | 53.09%421K | 34,749.63%47.05M | 3,069.18%25.24M |
| Net cash flow | ||||||||||
| Beginning cash position | -9.04%94.22M | 29.53%197.12M | -14.33%84.2M | 22.35%76.77M | -9.04%94.22M | -65.49%103.58M | 36.94%152.18M | -33.74%98.29M | -66.44%62.75M | -65.49%103.58M |
| Current changes in cash | 1,029.31%86.97M | 72.53%-15.93M | 109.51%112.92M | -79.08%7.44M | 57.26%-17.45M | 95.24%-9.36M | -667.56%-57.97M | 244.84%53.9M | 192.08%35.54M | 63.93%-40.83M |
| End cash Position | 92.31%181.19M | 92.31%181.19M | 29.53%197.12M | -14.33%84.2M | 22.35%76.77M | -9.04%94.22M | -9.04%94.22M | 36.94%152.18M | -33.74%98.29M | -66.44%62.75M |
| Free cash flow | -29.12%-40.56M | -94.26%-25.66M | -114.61%-12.23M | 113.18%5.54M | 86.30%-8.21M | 82.17%-31.41M | 44.67%-13.21M | 342.63%83.7M | 14.48%-42.01M | 12.80%-59.9M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025